A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures
Clinical trial NCT05159908 · COMPLETED
Trial details
- NCT number
- NCT05159908
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-08
- Primary completion
- 2023-08-21
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.